Released May 7, 2025, after the close
10-Q filed May 9, 2025, 39 days after period end · 0001636422-25-000069
Q1 2025 · 10-Q
Revenue$79.41M$79.41M +6.3% vs Q1 2024−0.2% vs Q4 2024
Net Income-$23.74M-$23.74M N/M vs Q1 2024N/M vs Q4 2024
EPS Diluted-$0.35-$0.35 N/M vs Q1 2024no prior Q4 2024 on file
Operating Income-$20,171,000N/M
Operating Cash Flow$280,000−97.3%
Free Cash Flowderived-$390,000N/M
Margins · derived
Operating margin-25.4%+5.1 pt vs Q1 2024
Net margin-29.9%−2.3 pt vs Q1 2024
What the release said
The release
Same quarter
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $79.41M | $74.72M | $73.87M | $68.09M |
| Net Income | -$23.74M | -$20.59M | -$33.19M | -$22.46M |
| EPS Diluted | -$0.35 | -$0.35 | -$0.60 | -$0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR